The inconspicuous nucleocapsid protein from coronaviruses can trigger hyperinflammation, an effect not typically seen in other viruses.
Device automatically reads and adjusts to skin tone for more accurate measurements of blood oxygen, pulse, and respiration
BlueWind plans to initiate a limited US market launch of Revi Extend in Q4 2026.
In the 1970s, PVC bags revolutionized the storage of blood and blood products for transfusion. Disposable plastic (PVC) bags replaced reusable glass bottles, making the process more convenient and safer from contamination. Over half a century later, the same disposable plastic bags are creating a new kind of problem because of microplastics (MPs). These tiny particles, less than 5 millimeters in size, are formed by the polymer degradation of plastic materials as they break down and age.
SINGAPORE, Aug. 6, 2026 /PRNewswire/ — Genesis MedTech has received CE Mark approval for its latest 8 mm video endoscope, marking an important milestone in minimally invasive imaging. Achieving 3D imaging, 4K resolution and fluorescence capability in an 8 mm endoscope has been one of the key engineering challenges in advanced surgical visualisation.
Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Omni Ultra Surgical System (Omni Ultra) for canaloplasty followed by trabeculotomy for the reduction of intraocular pressure (IOP) in adult patients with primary open-angle glaucoma (POAG).
BlueWind Medical announced today that it received FDA 510(k) clearance for Revi Extend, its next-generation implant.
A new open resource of cancer models has enabled researchers to create the first large-scale map of the genes that cancers rely on to survive, offering new avenues for research into better and less toxic treatments for patients.
Researchers from the Rolf Luft Research Center for Diabetes and Endocrinology at Karolinska Institutet have developed a targeted RNA technology to prepare pancreatic islet cells for transplantation.
Some 33 million Americans have severe food allergies. Now, researchers at Boston Children’s Hospital may have found a promising solution.